Next Article in Journal
Analysis of Adverse Effects of COVID-19 Vaccines Experienced by Healthcare Workers at Guizhou Provincial Staff Hospital, China
Next Article in Special Issue
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines
Previous Article in Journal
Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines
Previous Article in Special Issue
SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study
 
 
Review

Article Versions Notes

Vaccines 2022, 10(9), 1447; https://doi.org/10.3390/vaccines10091447
Action Date Notes Link
article xml file uploaded 2 September 2022 09:20 CEST Original file -
article xml uploaded. 2 September 2022 09:20 CEST Update -
article pdf uploaded. 2 September 2022 09:20 CEST Version of Record https://www.mdpi.com/2076-393X/10/9/1447/pdf-vor
article html file updated 2 September 2022 09:22 CEST Original file -
article xml file uploaded 5 September 2022 04:05 CEST Update -
article xml uploaded. 5 September 2022 04:05 CEST Update https://www.mdpi.com/2076-393X/10/9/1447/xml
article pdf uploaded. 5 September 2022 04:05 CEST Updated version of record https://www.mdpi.com/2076-393X/10/9/1447/pdf
article html file updated 5 September 2022 04:06 CEST Update -
article html file updated 28 February 2023 11:59 CET Update https://www.mdpi.com/2076-393X/10/9/1447/html
Back to TopTop